Catching Colorectal Cancer 'False Positives'...Cutting Unnecessary Colonoscopies Saves 600 Million Won
NHIS Slashes Fecal Occult Blood Test Positive Rate from 30% to 14%
Enhancing Accuracy and Safeguarding Financial Soundness through Quality Management of Screening Institutions
The National Health Insurance Service has achieved significant results in reducing unnecessary colonoscopies and greatly improving screening accuracy by investigating and managing the results of fecal occult blood tests for colorectal cancer conducted at health checkup institutions.
According to the National Health Insurance Service on February 26, an analysis of the status of fecal occult blood testing at colorectal cancer screening institutions in 2024 confirmed that some institutions showed an excessively high positive rate compared to the average. In response, the Service conducted on-site and written investigations in August 2025 on the top 93 institutions with the highest positive rates.
As a result, the average positive rate at these institutions plunged by 15.9 percentage points, from the previous 30.0% to 14.1% after the investigation. Consequently, 5,137 people were spared from undergoing unnecessary colonoscopy, and, according to the Service, this led to savings of approximately 665 million won in National Health Insurance finances.
For example, in the case of Hospital A, the positive rate had previously reached 48.5% due to examiner inexperience and the use of inappropriate, self-produced test materials. However, following the Service's corrective measures, the rate fell to 2.8%, indicating a substantial improvement in test accuracy.
Colorectal cancer is a malignant tumor that develops in the mucous membrane of the large intestine, with major symptoms including bloody stool, abdominal pain, and weight loss. The fecal occult blood test currently used for colorectal cancer screening checks for the presence of blood in the stool. It can be performed within two minutes using a test strip, and the results are easy to interpret, so it is widely used as a simple, basic screening test.
Every year, 6.5 million people undergo fecal occult blood testing for colorectal cancer screening, and about 270,000 of them receive positive results and are designated as candidates for colonoscopy. However, when this test is positive, the probability of actually detecting colorectal cancer is only 2% to 10%, and even when including adenomatous polyps, it is only about 20% to 30%. Therefore, the test has long been criticized for its limited accuracy in colorectal cancer screening.
There are two types of fecal occult blood tests: qualitative and quantitative. According to the Service's analysis, as of 2024, the positive rate for the qualitative method was 6.7%, while that for the quantitative method was 3.4%, showing a clear difference.
In particular, although the positive rate of fecal occult blood tests has been declining year by year, the proportion of colonoscopies performed on those who test positive has been on the rise. In 2024, among institutions performing colonoscopy, there was no difference in the positive rate for the quantitative method. However, for the qualitative method, institutions equipped with colonoscopy facilities recorded a positive rate of 6.9%, which was 2.3 percentage points higher than the 4.6% at institutions that only performed fecal testing.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
National Health Insurance Service President Jung Kisok said, "Lowering the false-positive rate in colorectal cancer screening and minimizing unnecessary additional examinations will not only reduce the psychological burden on examinees but also contribute to enhancing the sustainability of National Health Insurance finances," adding, "We will continue to pursue evidence-based quality management to create an environment in which the public can trust and undergo screening."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.